News

•  EUR 12 million financing comprising three tranches of EUR 4 million straight bonds.
• Clearing financial path to achieve major clinical milestones in view of regulatory approvals.

...

• Positive results from the first clinical study on 3 patients implanted between May and September 2018 • The implant technique, via laparoscopy and open surgery, was validated, surgical safety was also verified • Implantable in about 20 minutes with minimally invasive surgery, ARTUS is the first electronically activated artificial sphincter to treat stress urinary incontinence • ...

Affluent Medical announces today the positive conclusion of its OPTIMISE first clinical study for KALIOS, its adjustable mitral repair device. KALIOS has been implanted in five patients between January and May of the current year by Prof. Martin Andreas, Principal Investigator of this feasibility study, at the Vienna General Hospital (AKH). The first results of the study show that the primary endp...

Affluent Medical, a new French medtech player, today announces the postponement of its initial public offering (IPO) to list its shares for trading on the Euronext Growth market in Paris....